Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
9.42
+0.09 (0.96%)
At close: Nov 21, 2024, 4:00 PM
9.50
+0.08 (0.85%)
After-hours: Nov 21, 2024, 6:52 PM EST
Immunome Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -305.35 | -106.81 | -36.9 | -24.71 | -17.84 | -10.44 | |
| Depreciation & Amortization | 1.76 | 0.73 | 0.63 | 0.76 | 0.76 | 0.62 | |
| Asset Writedown & Restructuring Costs | 205.77 | 80.8 | - | - | - | - | |
| Loss (Gain) From Sale of Investments | -3.21 | -0.51 | - | - | - | - | |
| Stock-Based Compensation | 13.16 | 6.22 | 5.33 | 3.45 | 0.62 | 0.01 | |
| Other Operating Activities | - | - | - | -0.5 | 5.54 | 0 | |
| Change in Accounts Payable | -0.42 | -0.61 | -0.68 | 1.78 | 0.5 | 0.08 | |
| Change in Unearned Revenue | -10.13 | 15.98 | - | - | - | - | |
| Change in Other Net Operating Assets | 12.22 | -3.38 | 2.92 | 1 | -1.71 | 0.14 | |
| Operating Cash Flow | -86.19 | -7.57 | -28.69 | -18.23 | -12.13 | -9.6 | |
| Capital Expenditures | -52.48 | -0.83 | -0.25 | -0.08 | -0.59 | -0.23 | |
| Cash Acquisitions | 9.28 | 9.28 | - | - | - | - | |
| Investment in Securities | -81.62 | -38.93 | - | - | - | - | |
| Investing Cash Flow | -124.82 | -30.48 | -0.25 | -0.08 | -0.59 | -0.23 | |
| Long-Term Debt Issued | - | - | - | - | 0.5 | - | |
| Long-Term Debt Repaid | - | - | - | -0.11 | -0.45 | -0.61 | |
| Net Debt Issued (Repaid) | - | - | - | -0.11 | 0.05 | -0.61 | |
| Issuance of Common Stock | 235.64 | 0.41 | 0.03 | 28.66 | 44.87 | 0.01 | |
| Other Financing Activities | 40.3 | 116 | - | -0.78 | -6.02 | -0.04 | |
| Financing Cash Flow | 275.94 | 116.41 | 0.03 | 27.77 | 49.94 | 10.77 | |
| Net Cash Flow | 64.93 | 78.36 | -28.91 | 9.46 | 37.22 | 0.94 | |
| Free Cash Flow | -138.68 | -8.4 | -28.94 | -18.31 | -12.72 | -9.83 | |
| Free Cash Flow Margin | -1369.09% | -59.92% | - | - | - | - | |
| Free Cash Flow Per Share | -2.59 | -0.42 | -2.39 | -1.59 | -3.75 | -8.99 | |
| Cash Interest Paid | - | - | - | 0.01 | 0.03 | 0.11 | |
| Levered Free Cash Flow | -94.12 | 2.36 | -14.89 | -8.75 | -8.1 | -5.94 | |
| Unlevered Free Cash Flow | -94.12 | 2.36 | -14.89 | -8.74 | -8.08 | -5.88 | |
| Change in Net Working Capital | -13.25 | -14.19 | -2.46 | -2.89 | 1.2 | -0.2 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.